-Reuters
Ocular Therapeutix Q3 EPS $(0.31) Misses $(0.24) Estimate, Sales $11.91M Miss $14.27M Estimate
Ocular Therapeutix (NASDAQ:OCUL) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.24) by 29.17 percent. This is a 34.78 percent decrease over losses of $(0.23) per share
